Literature DB >> 16110318

Wilms' tumour: connecting tumorigenesis and organ development in the kidney.

Miguel N Rivera1, Daniel A Haber.   

Abstract

Wilms' tumour, or nephroblastoma, is a common childhood tumour that is intimately linked to early kidney development and is often associated with persistent embryonic renal tissue and other kidney abnormalities. WT1, the first gene found to be inactivated in Wilms' tumour, encodes a transcription factor that functions as both a tumour suppressor and a critical regulator of renal organogenesis. Our understanding of the roles of WT1 in tumour formation and organogenesis have advanced in parallel, providing a striking example of the intersection between tumour biology, cellular differentiation and normal organogenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16110318     DOI: 10.1038/nrc1696

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  122 in total

1.  Glypican 3 overexpression in primary and metastatic Wilms tumors.

Authors:  Maria Tretiakova; Debra L Zynger; Chunyan Luan; Nicole K Andeen; Laura S Finn; Masha Kocherginsky; Bin T Teh; Ximing J Yang
Journal:  Virchows Arch       Date:  2014-11-04       Impact factor: 4.064

2.  WT1: a weak spot in KRAS-induced transformation.

Authors:  Silvia Licciulli; Joseph L Kissil
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 3.  Transcriptional mechanisms regulating Ca(2+) homeostasis.

Authors:  Michael F Ritchie; Yandong Zhou; Jonathan Soboloff
Journal:  Cell Calcium       Date:  2010-11-13       Impact factor: 6.817

4.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

5.  Functional Enhancers Shape Extrachromosomal Oncogene Amplifications.

Authors:  Andrew R Morton; Nergiz Dogan-Artun; Zachary J Faber; Graham MacLeod; Cynthia F Bartels; Megan S Piazza; Kevin C Allan; Stephen C Mack; Xiuxing Wang; Ryan C Gimple; Qiulian Wu; Brian P Rubin; Shashirekha Shetty; Stephane Angers; Peter B Dirks; Richard C Sallari; Mathieu Lupien; Jeremy N Rich; Peter C Scacheri
Journal:  Cell       Date:  2019-11-21       Impact factor: 41.582

Review 6.  Wilms tumor--a renal stem cell malignancy?

Authors:  Naomi Pode-Shakked; Benjamin Dekel
Journal:  Pediatr Nephrol       Date:  2011-04-16       Impact factor: 3.714

7.  Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.

Authors:  Silvestre Vicent; Ron Chen; Leanne C Sayles; Chenwei Lin; Randal G Walker; Anna K Gillespie; Aravind Subramanian; Gregory Hinkle; Xiaoping Yang; Sakina Saif; David E Root; Vicki Huff; William C Hahn; E Alejandro Sweet-Cordero
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

8.  Wilms tumor arising in a child with X-linked nephrogenic diabetes insipidus.

Authors:  Reyhan El-Kares; Pierre-Alain Hueber; Miriam Blumenkrantz; Diana Iglesias; Kim Ma; Nada Jabado; Daniel G Bichet; Paul Goodyer
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

9.  RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1.

Authors:  Tadateru Nishikawa; Jonathan M Wojciak; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2020-09-29       Impact factor: 3.162

10.  HER2/neu expression: a predictor for differentiation and survival in children with Wilms tumor.

Authors:  Seham M Ragab; Rehab M Samaka; Tahany M Shams
Journal:  Pathol Oncol Res       Date:  2009-07-17       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.